While a direct Alien: Covenant sequel might never happen, a franchise writer has revealed what happened to Michael Fassbender's David next.

Ridley Scott's inimitable 1979 sci-fi thriller, Alien, expertly ratchets up the tension by not having the titular alien show up on screen until roughly an hour into the film. Following in Scott's ...

Caldera Therapeutics has burst onto the scene with $112.5 million in combined series A cash the Massachusetts biotech will use to fund development of an inflammatory bowel disease (IBD) drug licensed ...

Amneal Pharmaceuticals and VantAI have joined the ranks of companies to decide that a new year demands a new look, each unveiling fresh branding this week, aligned with their respective plans for 2026 ...

The ICE agent who opened fire in Minneapolis Wednesday was dragged 100 yards by an illegal migrant in Minnesota last June after his arm was trapped inside the vehicle during a traffic stop, The Post ...

Charles River Laboratories has struck a $510 million deal to buy a nonhuman primate (NHP) provider, furthering efforts to strengthen its supply chain after a turbulent period. The service provider ...

Initial $75M Series A investment from founding investors Atlas Venture, LAV and venBio in April 2025, recently augmented by $37.5M Series A-1 funding led by Omega Funds, with participation from ...